Domain Therapeutics
Series ADomain Therapeutics raised €40M in a Series A round in May 2022. The company is based in Strasbourg,, France. Investors in the round: 3B Future Health Fund, adMare BioInnovations, CTI Life Sciences and 7 others. Data as of 4 Nov 2026.
Amount raised
€40M
€39,795,338
Native amount
42,000,000 USD
Stage
Series A
series a
Investors
10
Provenance & confidence
High confidenceAmount
42,000,000 USD
ECB-at-date → €40M · rate 1.0554 on 2022-05-10
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
10 named3B Future Health FundadMare BioInnovationsCTI Life SciencesOmnes CapitalPanacea VentureSchroders CapitalSeventure PartnersTheodorusTurenne CapitalViva BioInnovator
Date
May 2022
Round type
series a
Amount (EUR)
€40M
Other rounds
same companyRelated news
- Domain Therapeutics Raises $42M in Series A Financingfinsmes.com · 2022-05